NASDAQ · Healthcare · Biotechnology
ProQR Therapeutics N.V.
PRQR
ProQR Therapeutics N. CEO Daniel Anton de Boer · Market cap $181.1M.
$1.72
-0.06 · -3.37%
52w hi $3.1052w lo $1.33
Off 52w high 44.8%
72
NOTABLE
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
Avg PT $3.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 31 | Daniel Anton De Boer | Chief Executive Officer | Buy | 200,000 | $1.77 | +$354K | 72 |
| Jul 17 | Bart Filius | Buy | 150,000 | $1.72 | +$258K | 63 | |
| Jul 09 | Daniel Anton De Boer | Chief Executive Officer | Buy | 150,000 | $1.74 | +$261K | 72 |
| Jul 07 | Daniel Anton De Boer | Chief Executive Officer | Buy | 150,000 | $1.59 | +$239K | 72 |
| Jun 26 | Bart Filius | Buy | 150,000 | $1.54 | +$231K | 63 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug